Carbidopa
SIAL/C0460000 - European Pharmacopoeia (EP) Reference Standard
Synonym: (S)
CAS Number: 38821-49-7
Empirical Formula (Hill Notation): C10H14N2O4 · H2O
Molecular Weight: 244.24
MDL Number: MFCD00889211
Linear Formula: C10H14N2O4 · H2O
Product Type: Chemical
API family | carbidopa |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C10H14N2O4.H2O/c1-10(1 |
InChI key | QTAOMKOIBXZKND-PPHPATTJSA |
manufacturer/tradename | EDQM |
SMILES string | O.C[C@@](Cc1ccc(O)c(O)c1) |
Application: | Carbidopa EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia. |
General description: | Carbidopa is a dopaminergic drug, which is known to inhibit the conversion of dopa to dopamine. It is used in combination with levodopa for the effective treatment of restless legs syndrome and periodic leg movements in sleep. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H302 - H319 |
Precautionary statements | P264 - P270 - P280 - P301 + P312 - P305 + P351 + P338 - P337 + P313 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
UNSPSC | 41116107 |